About five percent of Philadelphia residents have a past or current hepatitis A, B, or C infection. Many people are unaware of their infection. Hepatitis C (or HCV) is the most common blood-borne viral infection in the US. If left untreated it can lead to serious liver problems such as cirrhosis or cancer. There are…
C a Difference is a comprehensive hepatitis C (HCV) testing and linkage-to-care program at FIGHT. C a Difference provides care for patients diagnosed with chronic HCV those at risk for HCV infection.
C a Difference Team Introducing the C a Difference team. The program focuses on visualizing a future free of hepatitis C. It’s a multidisciplinary approach to care, delivered by a team of passionate advocates who built this program from scratch. C a Difference develops and implements best practices through testing and linkage to care services,…
PrEP is one pill swallowed once a day that can prevent HIV infection by more than 95%. Philadelphia FIGHT is committed to providing access to PrEP to all individuals, regardless of their health insurance status or ability to pay.
